Xofigo TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: radium (223ra)
Pack: Xofigo 6.6 MBq/6 mL injection, 6 mL vial
Brand name
(ARTG)
: XOFIGO radium (223Ra) dichloride 6.6 MBq per 6 mL solution for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
XOFIGO is indicated for the treatment of castration-resistant prostate cancer patients with symptomatic bone metastases and no known visceral metastatic disease.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear and colourless solution
Storage conditions
(ARTG)
- Store below 40 degrees Celsius
- Store in Original Container
- Shelf lifetime is 28 Days.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
- 1 vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient radium (223ra)
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
